Visceral leishmaniasis (VL) is a severe and potentially fatal neglected tropical disease,
being considered a public health concern in many countries worldwide. There are still no …

Visceral leishmaniasis (VL) or Kala‐azar, is the most lethal form of leishmaniasis, is still
prevalent in many countries where it is endemic. It is a threat to human life caused by …

Leishmania is an intracellular parasite with different species pathogenic to humans and
causing the disease leishmaniasis. Leishmania donovani causes visceral leishmaniasis …

Visceral leishmaniasis (VL) is the most severe clinical form of leishmaniasis, fatal if
untreated. Vaccination is the most cost-effective approach to disease control; however, to …

Aim Leishmania donovani, the causative agent for visceral leishmaniasis (VL), modulates
host monocytes/macrophages to ensure its survival. However, knowledge regarding the host …

The search for new drugs against neglected parasitic diseases has experienced a major
boost in recent years with the incorporation of bioimaging techniques. Visceral …

Introduction Cutaneous, muco-cutaneous and visceral leishmaniasis occur due to an
infection with the protozoan parasite Leishmania. The current therapeutic options are limited …

Transcriptional analysis is a useful approximation towards the identification of global
changes in host-pathogen interaction, in order to elucidate tissue-specific immune …

The gold standard for diagnosis of leishmaniasis is the microscopic detection of
amastigotes/Leishman Donovan (LD) bodies, but its moderate sensitivity necessitates the …

In recent years, several advances have been observed in vaccinology especially for
neglected tropical diseases (NTDs). One of the tools employed is epitope prediction by …